Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_assertion description "[Furthermore, anti-IL-6R mAb could provide novel therapy for Castleman's disease and MR16-1 should be a useful tool to estimate therapeutic potential of IL-6 antagonists in a variety of murine models for human disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_assertion evidence source_evidence_literature NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_assertion SIO_000772 12633573 NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_assertion wasDerivedFrom befree-20140225 NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_assertion wasGeneratedBy ECO_0000203 NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.
- befree-20140225 importedOn "2014-02-25" NP544614.RAEL-epEJeyHuTTeSEWwuOt2ODU3kvybnp5hyP1g2xk-4130_provenance.